Introduction
The ability of many viruses to compromise immunological function in mammals has been repeatedly demonstrated [1 ] . Further, it has been shown that many oncogenic viruses cause malignant transformation in an immunosuppressed, otherwise resistant host [2] , or show a decreased latency period from infection to tumor appearance when compared to an immunologically competent sibling [3] .
Moloney Sarcoma Virus (MSV), first isolated by Moloney and associates [4] , has the capability of producing a malignant neoplasm, pathologically characterized as a rhabdomyosarcoma [5] , which spontaneously regresses in an immunologically intact animal [6] . The tumor does not regress in immunologically compromised [7] , immature [8] , or congenitally athymic [ 10] mice but progressively grows in the host, until death ensues.
Work has previously been done on the virologic [11] and pathologic [12] nature of MSV. Some immunological characterization has been done [ 13] strongly suggesting that an intact cell-mediated immune function is necessary for tumor regression. A marked depression of phytohemagglutinin reactivity has been observed in cell culture of C57B 1/6N mice bearing primary MSV4nduced tumors. This defect was most pronounced 14 days after virus inoculation and was reversed after regression of the tumor [14] . Data strongly suggest that these suppressor cells appear to be macrophages [15, 16] . Little has been reported in mapping the immunological capabilities of infected BALB/c mice during the course of MSV tumor formation. It was with this objective that the daily nonspecific immune capabilities of MSV infected BALB/c mice were assessed.
Material and Methods

Mice
Male BALB/c mice, aged 6-8 weeks (Texas Inbred Mice Co., Houston, Texas) were used in all experiments. Male Swiss Webster Mice, derived from our own colony, were used for mixed lymphocyte reactions. All mice were maintained on laboratory diet and water ad libitum.
Virus
Virus preparation used to induce tumors was MSV, lot MSV-B-85, kindly supplied by University Laboratories, Inc., Highland Park, N.J. Supplied stock solution, assayed at 6.2 log focal forming units (flu) per rnl of stock, was diluted 10 -1 using phosphate buffered saline (PBS), pH 7.4. A 0.1 ml aliquot was injected intramuscularly (i.m.) into the right hind thigh of each animal tested. Control injections consisted of 0.1 ml PBS injected i.m. into the left hind thigh. Triplicate test and control animals were killed at 1-day intervals after challenge.
Tumor grading
Daily, both hind legs of each animal were measured using a vernier caliper. The diameter of each thigh was measured adjacent to the knee, then a second measurement was taken in the same plane perpendicular to the first. The tumor volume was computed using the formula V = 0.2 (ab) 2, where "V" is volume, "a" is the maximum diameter measured and "b" is the diameter perpendicular to "a".
Blastogenic response of lymphocytes to mitogens
The daily assessment of immunological competence was assayed using the lymphocyte culture method of Zatz et al. [17] . Spleens were aseptically removed from infected animals, placed in a sterile dish containing RPMI-1640 culture medium (Grand Island Biological Co., Grand Island, N.Y.), and finely minced. A single cell suspension was prepared by passing the spleen through decreasing diameter needles. The cells were washed once and resuspended in RPMI. Cell concentrations were determined and the suspension diluted to contain 1 • 106 splenic lymphocytes per ml with RPMI supplemented with 10% fetal calf serum (Gibco), 100 U/ml penicillin, and 100/lg/ml streptomycin (Difco, Detroit, Michigan), and brought to a final pH of 7.4 with 7.0% Na2HCOa.
2 ml aliquots of cells were dispensed in triplicate into 16 X 100 mm glass tubes for each test run. The mitogens used in the experiment were phytohemagglutinin-p (PHA-P) (Difco, Detroit, Michigan), Concanavalin A (Con A) (Calbiochem, La Jolla, CA), and pokeweed mitogen (PWM) (Gibco). Final concentrations of mitogens were 1.0% PHA-P, 1/ag Con A and 1% PWM per tube. Medium was added to a fourth set of cells to serve as a control.
All tubes were incubated for 24 h at 37°C, 5% CO2, humidified. At 24 h, each tube was pulsed with 0.5/tCi [3H]methyl-thymidine in 0.1 ml, specific activity 1.9 Ci/mmol and returned to incubation for an additional 24 h.
At 48 h, all tubes were harvested by vacuum filtration on Whatman GF/c glass filter pads. The pads were allowed to air-dry, transferred to scintillation vials containing 5 ml Liquifluor (New England Nuclear, New Haven, Conn.) and counted in a Beckman LS-200 scintillation counter.
Means and standard errors of [3H] counts per min (cpm) were calculated for all samples and a blastogenic index (B.I.) computed for each mitogen. B.I. was derived by dividing mean control cpm into test cpm. A B.I. of 2.0 or greater was considered significant for cell-mediated immune reactivity.
Mixed Lymphocyte Reaction
Mixed Lymphocyte Reaction (MLR) was performed to further investigate cell-mediated immunity The cells were prepared in the manner previously described. In addition, cells from spleens of SwissWebster (SW) mice previously irradiated with 700 R total irradiation were also prepared in the manner previously described serving as stimulator cells. In triplicate, 2 ml aliquots of BALB/c spleen cells were dispensed as controls, while 1 ml aliquots were dispensed as tests. To the tests were added 1 ml SW spleen cells.
All tubes were incubated for 5 days at 37°C, 5% CO2, humidified. On day 4, all tubes were pulsed with [aH] methyl-thymidine as previously described and harvested and counted 24 h later. A B.I. was also calculated for each MLR.
Results
Tumor
The progression of MSV-induced tumor was essentially identical to that previously reported [9] . Fig.  1 shows the peak tumor size to be at day 12 with a secondary peak at day 15, followed by nearly total regression of tumor by day 21. tinuing to decline until day 15. A spontaneous repair occurred, bringing the PHA-P response back to near normal value by day 21. The response of Con A (Fig. 2 ) remained relatively unchanged until day 13 when it increased exponentially, remaining elevated until day 17.
Response to mitogens
The response to PWM (Fig. 2 ) remained relatively unchanged, until day 13, when the response dropped significantly. However, this was transient and was repaired by day 14.
The MLR response (Fig. 2) shows a decreased response on day 14-15, paralleling the PHA-P response.
Discussion
The fact that regression of MSV-induced tumor may depend upon the immunological status of the host led us to investigate the possible change in func-._t2 8' t~ rn tional lymphocyte population during MSV infection. The results gave an interesting insight not only to the effect of MSV on cellular immunocompetence but to the maturation sequence of T lymphocytes as well.
A comparison of PHA-P and Con A response as a function of tumor size suggests that, as the tumor reaches a maximum size, the PHA reactive T2 cells are simply used up in the fight against the tumor, depleting these cells in the spleen. Stobo and associates [18] have extensively characterized two populations of T lymphocytes. One population is characterized as being Con A responsive and PHA unresponsive. This correlates with the T l cell of Hooper et al. [19] . The second population is both Con A and PHA responsive, correlating with T2 cells. The comparison shows that, as the PHA response begins to decrease, the Con A response increases dramatically. It is suggested that perhaps, as the T2 population is depleted, some stimulus causes the conversion of pre-T lymphoblasts into Con A responsive Tl cells, which later mature into T2 cells. This view is supported by the observation that a splenic enlargement occurs at day 12 and continues until day 21.
The possible uses of this MSV system may prove quite interesting. From the results presented here, it is proposed that the relative maturation steps from uncommitted lymphocyte to immunologically mature T-lymphocyte encompasses several steps. Further, it is proposed that these steps are not equal in duration, rather the conversion from T1 to T2 cells is longer and more complicated than the conversion from pre-T to TI. Further work must be done to actually plot this maturation sequence.
